entertainment -WSS

entertainment

author：explore 2025-09-30 00:37:31 - browse：58

Jennifer Doudna Feng Zhang CRISPR — CRISPR pioneers Jennifer Doudna and Feng Zhang Illustration: STAT; Photos: AP, Getty

The revolution started in silence.

Jennifer Doudna and Emmanuelle Charpentier, now Nobelists, published their first paper announcing a new enzyme for editing DNA in Science in June 2012. It was called CRISPR-Cas9. It wasn’t until January 2013 that the first paper showing the enzyme would work in cells, from Feng Zhang, was published, also in Science. A similar paper from George Church came out at the same time.

No major media outlet covered the papers. The first story on CRISPR was published that March. But within the ivory tower of academia, it was clear something big was building, as requests for the technology poured in from other researchers and Zhang set up an assembly line in his laboratory to distribute it, with students carrying carefully packed samples to a FedEx office down the street.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： FDA approval of Sarepta Duchenne genetic therapy gives me hope
Next article： Key Senate panel to consider PBM, drug pricing reform package

focus

WSS

CEOs share strategies for surviving biotech slump

After Sarepta trial failure, Duchenne families brace for more debate

Sarepta Duchenne therapy fails to meet primary endpoint in trial

Lawmakers consider Medicare pay reforms for doctors

How to convince healthy people to buy insurance

CEOs share strategies for surviving biotech slump

hotspot

entertainment

focus

What does generative AI mean for health care? We asked experts

Key Senate panel to consider PBM, drug pricing reform package

Medical leaders decry Supreme Court decision on affirmative action

NIH confirmation hearing shows politicization of research

Medical leaders decry Supreme Court decision on affirmative action

UnitedHealth’s board chair also owns a personal investment firm

23andMe had bad news about my health. I wish a person had delivered it

Travis Kelce and the trap of celebrity vaccine endorsements

How to save PrEP access — and even expand it

Infant mortality in U.S. rose last year for first time in decades: CDC

focus

FDA gives detailed accounting of AI

Readout Newsletter: Medeor's stem cell study, Moderna's stock dip

How to convince healthy people to buy insurance

Readout Newsletter: Medeor's stem cell study, Moderna's stock dip

STAT Summit: Biotech founders on deal

Inari Medical to buy amputation prevention company LimFlow

hotspot

focus

focus

explore